US 11,951,327 B2
Heart arrhythmia non-invasive treatment device and method
Adriano Garonna, Geneva (CH); and Giovanni Leo, Cologny (CH)
Assigned to EBAMed SA, Geneva (CH)
Filed by EBAMed SA, Geneva (CH)
Filed on Apr. 11, 2022, as Appl. No. 17/717,310.
Application 17/717,310 is a continuation of application No. 16/764,967, granted, now 11,298,565, previously published as PCT/EP2018/081455, filed on Nov. 15, 2018.
Claims priority of application No. 17202164 (EP), filed on Nov. 16, 2017.
Prior Publication US 2022/0305288 A1, Sep. 29, 2022
Int. Cl. A61N 5/00 (2006.01); A61N 5/10 (2006.01); G16H 40/60 (2018.01)
CPC A61N 5/1037 (2013.01) [A61N 5/1049 (2013.01); A61N 5/1068 (2013.01); G16H 40/60 (2018.01); A61N 2005/1058 (2013.01); A61N 2005/1061 (2013.01); A61N 2005/1087 (2013.01); A61N 2005/1097 (2013.01)] 20 Claims
OG exemplary drawing
 
1. Heart arrhythmia treatment device comprising:
a charged particle emitting system for generating a charged particle beam with required properties for ablation of a targeted tissue of a heart of a patient, the charged particle emitting system being configured to deliver a Bragg peak of the charged particle beam to the targeted tissue;
an ultrasound cardiac imaging system configured to image a relevant region of the heart that is relevant to assess motion of the targeted tissue and corresponding cardiac and respiratory cycle phases of the patient; and
a control system that instructs the charged particle emitting system to generate the required properties of the charged particle beam in accordance with a relevant irradiation plan and when to generate the charged particle beam based on information of the cardiac and respiratory cycle phases provided by the ultrasound cardiac imaging system, the information being acquired during a treatment stage of the patient.